Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 20, 2019 09:15 ET | Source: Ritter Pharmaceuticals, Inc.

Ritter Pharmaceuticals Provides Phase 3 Liberatus Clinical Trial and Regulatory Update

LOS ANGELES, June 20, 2019 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of innovative therapeutic products that modulate...
June 20, 2019 09:00 ET | Source: Turning Point Therapeutics, Inc.

Turning Point Therapeutics Initiates Phase 2 Registrational Portion of TRIDENT-1 Clinical Study

SAN DIEGO, June 20, 2019 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing novel drugs to address treatment resistance, today announced...
June 20, 2019 09:00 ET | Source: Royal Philips

Philips extends advanced automation capabilities on its EPIQ CVx cardiology ultrasound platform, making accurate exams faster and easier to conduct

June 20, 2019 With new release, clinicians can reduce the number of touches of the system by 21% per exam, equivalent to more than 400 exams each yearPlatform provides advanced automation for...
June 20, 2019 08:30 ET | Source: Celsion CORP

Celsion Announces IRB Approval to Begin a Clinical Study of ThermoDox® Plus High Intensity Focused Ultrasound in Breast Cancer Patients at University Medical Center Utrecht in the Netherlands

An Investigator-Sponsored Phase I Safety and Feasibility Study Estimated to Begin Enrollment in the Second Half of 2019 The Study Further Reinforces the Broad Potential of ThermoDox to Treat a Range...
June 20, 2019 08:30 ET | Source: Progenics Pharmaceuticals Inc.

Progenics Pharmaceuticals to Initiate a Basket Trial by Year End to Support an Expanded Label for AZEDRA® (iobenguane I 131) in Multiple MIBG Avid Neuroendocrine Tumors

NEW YORK, June 20, 2019 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), (“Progenics” or the “Company”), an oncology company developing innovative targeted medicines and artificial...
June 20, 2019 08:00 ET | Source: Albireo Pharma, Inc.

Albireo Announces Launch of “PFIC Voices”

New Initiative to Create Awareness and Understanding of Life-Threatening Pediatric Liver Disease Announced new PFIC Voices website, www.PFICvoices.com BOSTON, June 20, 2019 (GLOBE NEWSWIRE) --...
June 20, 2019 08:00 ET | Source: OPKO Health, Inc.

OPKO Health Submits De Novo Request to the U.S. FDA for the 4Kscore® Test

MIAMI, June 20, 2019 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) announces that the Company has submitted a de novo request to the U.S. Food and Drug Administration (FDA) seeking regulatory...
June 20, 2019 08:00 ET | Source: Spero Therapeutics, Inc.

Spero Therapeutics Announces Collaboration with Bill & Melinda Gates Medical Research Institute to Develop SPR720 for Tuberculosis

CAMBRIDGE, Mass., June 20, 2019 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and...
June 20, 2019 08:00 ET | Source: Predictive Technology Group, Inc.

Predictive Technology Group Announces the Presentation of New Genetic Findings in Endometriosis at the 35th Annual Meeting of the European Society of Human Reproduction and Embryology

SALT LAKE CITY, June 20, 2019 (GLOBE NEWSWIRE) -- Predictive Laboratories, a wholly owned subsidiary of Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data analytics for...
June 20, 2019 07:52 ET | Source: BioSig Technologies, Inc.

BioSig Technologies Issues June 2019 Shareholder Letter

Santa Monica, CA, June 20, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical device company developing a proprietary biomedical signal...
June 20, 2019 07:45 ET | Source: BeiGene, LTD.

BeiGene Presents Pivotal Phase 2 Clinical Results of Zanubrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma at the 15th International Conference on Malignant Lymphoma (ICML)

CAMBRIDGE, Mass. and BEIJING, China, June 20, 2019 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and...
June 20, 2019 07:30 ET | Source: Theratechnologies

Theratechnologies lance deux campagnes publicitaires aux États-Unis axées vers les usagers potentiels de TROGARZO(MD) et d’EGRIFTA(MD)

MONTRÉAL, 20 juin 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) est heureuse d’annoncer le lancement de deux campagnes publicitaires axées vers les usagers...
June 20, 2019 07:30 ET | Source: Theratechnologies

Theratechnologies Launches Direct-to-Consumer Campaigns for TROGARZO® and EGRIFTA® in the United States

MONTREAL, June 20, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce the launch of two direct-to-consumer campaigns for TROGARZO® (ibalizumab-uiyk)...
June 20, 2019 07:30 ET | Source: T2 Biosystems, Inc.

T2 Biosystems Introduces New Clinical Data and Updates Regarding Expanding Capabilities of its Rapid Diagnostic Technology at ASM Microbe 2019

LEXINGTON, Mass., June 20, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative medical diagnostic products for critical unmet needs in...
June 20, 2019 07:00 ET | Source: Trevena Inc.

Trevena Announces Initiation of Healthy Volunteer Study for Oliceridine

CHESTERBROOK, Pa., June 20, 2019 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN) (“Trevena” or the “Company”), a biopharmaceutical company focused on the development and commercialization of novel...
June 20, 2019 07:00 ET | Source: Revive Therapeutics Ltd.

Revive Therapeutics Announces Cannabis Product Derivative Manufacturing and Development Facility

TORONTO, June 20, 2019 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. ("Revive" or the "Company") (TSX VENTURE: RVV) (OTCQB: RVVTF), a specialty cannabis company focused on the research, development,...
June 20, 2019 07:00 ET | Source: Axovant Sciences Ltd.

Axovant and Yposkesi Sign Strategic Gene Therapy Development and Manufacturing Partnership

BASEL, Switzerland and CORBEIL-ESSONNES, France, June 20, 2019 (GLOBE NEWSWIRE) -- Axovant Gene Therapies Ltd. (NASDAQ: AXGT), a clinical-stage company developing innovative gene therapies, today...
June 20, 2019 06:19 ET | Source: Research and Markets

Global Drugs of Abuse Testing Market - Forecast to 2023 with Abbott, Bio-Rad Labs, Danaher Corp, Roche, and Thermo Fisher Scientific Leading the Competition

Dublin, June 20, 2019 (GLOBE NEWSWIRE) -- The "Drugs of Abuse Testing Market by Product and Geography - Global Forecast and Analysis 2019-2023" report has been added to ...
June 20, 2019 06:00 ET | Source: Parallax Health Sciences, Inc.

Parallax Health Sciences Announces Initiative to Obtain a 510(K) Clearance for its Fotodigm® Enabled Remote Patient Monitoring Platform

Positions Fotodigm® to be Issued a CPT Code for Medical Billing SANTA MONICA, CA, June 20, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Parallax Health Sciences, Inc. (OTCQB: PRLX) (''Parallax''...
June 20, 2019 05:24 ET | Source: Research and Markets

Cardiac Defibrillators: Insights Into & Future of the Global Market to 2024 -- Focus Grows on Building Compact Defibrillators

Dublin, June 20, 2019 (GLOBE NEWSWIRE) -- The "Cardiac Defibrillators: Global Market Analysis, Trends, and Forecasts" report has been added to ResearchAndMarkets.com's offering. ...
June 20, 2019 05:00 ET | Source: TeraRecon, Inc

TeraRecon Receives First-of-Kind FDA Determination

DURHAM, N.C., June 20, 2019 (GLOBE NEWSWIRE) -- Advanced visualization and artificial intelligence (AI) technology provider, TeraRecon, today announced it has successfully completed an FDA...
June 20, 2019 04:41 ET | Source: Research and Markets

The World Market for Leukemia Therapeutics 2019-2024 - Novartis is Leading the Market, Owing to Its Strong Sales Channel & Innovative Therapies

Dublin, June 20, 2019 (GLOBE NEWSWIRE) -- The "Leukemia Therapeutics Market by Type (CLL, ALL, CML, AML), Treatment Type (Chemotherapy & Targeted Drugs), Mode of Administration (Oral,...
June 20, 2019 04:34 ET | Source: Research and Markets

Insights Into the Global Market for Anesthesia & Respiratory Devices, 2019 to 2026

Dublin, June 20, 2019 (GLOBE NEWSWIRE) -- The "Insights Into the Global Market for Anesthesia & Respiratory Devices, 2019 to 2026" report has been added to ResearchAndMarkets.com's ...
June 20, 2019 04:33 ET | Source: Research and Markets

In Vitro Diagnostics (IVD) Market Anticipated to Surpass $100 Billion by 2026 - Molecular Diagnostics Expected to Witness the Fastest Growth

Dublin, June 20, 2019 (GLOBE NEWSWIRE) -- The "Global In Vitro Diagnostics (IVD) Market by Product, Technology, Application, and End-use (2019-2026)" report has been added to ...
June 20, 2019 01:00 ET | Source: INNATE PHARMA

Innate Pharma organise une conférence téléphonique avec un expert sur le rationnel et le design de l’essai « TELLOMAK » d’IPH4102

INNATE PHARMA ORGANISE UNE CONFÉRENCE TÉLÉPHONIQUE AVEC UN EXPERT SUR LE RATIONNEL ET LE DESIGN DE L’ESSAI « TELLOMAK » D’IPH4102 Marseille, 20 juin 2019, 07h00 Innate Pharma SA (la...
June 20, 2019 01:00 ET | Source: INNATE PHARMA

Innate Pharma to host key opinion leader call on IPH4102 “TELLOMAK” clinical trial design and rationale

INNATE PHARMA TO HOST KEY OPINION LEADER CALL ON IPH4102 “TELLOMAK” CLINICAL TRIAL DESIGN AND RATIONALE Marseille, France, June 20, 2019, 07:00 AM CEST Innate Pharma SA (the...
June 19, 2019 13:08 ET | Source: Bavarian Nordic A/S

Bavarian Nordic Initiates Phase 3 Trial of Freeze-dried MVA-BN® Smallpox Vaccine

COPENHAGEN, Denmark, June 19, 2019 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today the initiation of a pivotal Phase 3 trial of the freeze-dried formulation of MVA-BN® smallpox vaccine...
June 19, 2019 12:14 ET | Source: Research and Markets

The Worldwide Market for Optical Pulse Sensors (2019-2024): Smart Bands Expected to Hold Significant Market Share

Dublin, June 19, 2019 (GLOBE NEWSWIRE) -- The "The Worldwide Market for Optical Pulse Sensors (2019-2024)" report has been added to ResearchAndMarkets.com's offering. The...
June 19, 2019 11:38 ET | Source: Research and Markets

Membrane Filtration Market - Global Forecast to 2025 - Growth Potential in Asian and Middle Eastern Markets

Dublin, June 19, 2019 (GLOBE NEWSWIRE) -- The "Membrane Filtration Market by Type (RO, UF, MF, NF), Application (Water, Dairy, Drinks & Concentrates, Wine & Beer), Module Design (Spiral,...
June 19, 2019 11:28 ET | Source: NutraNomics, Inc.

NutraNomics, Inc. (NNRX) Announces Establishment of UK and Domestic Subsidiaries for Expansion and Farming Opportunities Along with a New Huntington Beach, California Headquarters

Portland, OR, June 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- NutraNomics, Inc. (NNRX) announces establishment of UK and Domestic Subsidiaries for expansion and farming opportunities along...
June 19, 2019 11:21 ET | Source: BeiGene, LTD.

BeiGene Announces Updated Results from Two Ongoing Clinical Trials of Zanubrutinib in Patients with Mantle Cell Lymphoma in Presentations at the 15th International Conference on Malignant Lymphoma (ICML)

CAMBRIDGE, Mass. and BEIJING, China, June 19, 2019 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and...
June 19, 2019 11:05 ET | Source: Karyopharm Therapeutics Inc.

Karyopharm Reports Updated Data from the Phase 2b SADAL Study at the 2019 International Conference on Malignant Lymphoma

-- Single-Agent Oral Selinexor Induces a 28.3% Overall Response Rate, Including a 10.2% Complete Response Rate -- -- Amongst Patients with a Complete or Partial Response, Median Duration of Response...
June 19, 2019 09:45 ET | Source: Elbit Imaging Ltd.

ELBIT IMAGING ANNOUNCES THAT GAMIDA CELL AND LONZA ESTABLISH COMMERCIAL MANUFACTURING AGREEMENT FOR OMIDUBICEL

Tel Aviv, Israel, June 19, 2019 (GLOBE NEWSWIRE) -- Elbit Imaging Ltd. (TASE, UTC UC: EMITF) (“Elbit” or the “Company”) announced today that on June 19, 2019, Gamida Cell Ltd. (Nasdaq: GMDA)...
June 19, 2019 09:26 ET | Source: Emerald Health Pharmaceuticals

Emerald Health Pharmaceuticals to Present Preclinical Data at the 29th Annual Symposium of the International Cannabinoid Research Society

SAN DIEGO, CA, June 19, 2019 (GLOBE NEWSWIRE) -- Emerald Health Pharmaceuticals Inc. (EHP), a clinical-stage company developing medicines based on cannabinoid science, will present preclinical data...
June 19, 2019 09:02 ET | Source: CytoDyn Inc.

CytoDyn Submits 510(k) Pre-Submission Application to U.S. FDA for ProstaGene™ Prognostic Test

VANCOUVER, Washington, June 19, 2019 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late stage biotechnology company developing leronlimab (PRO 140), a CCR5...
June 19, 2019 09:00 ET | Source: Royal Philips

Philips receives FDA premarket approval for its HeartStart OnSite and HeartStart Home defibrillators

June 19, 2019 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the Center for Devices and Radiological Health...
June 19, 2019 08:30 ET | Source: Progenics Pharmaceuticals Inc.

Progenics to Mail Letter to Shareholders

Highlights Velan’s Faulty Assertions and Ongoing Efforts to Mislead Progenics Shareholders Urges Shareholders to Vote “For” All of Company’s Directors on the WHITE Proxy Card NEW YORK, June 19,...
June 19, 2019 08:30 ET | Source: Ultragenyx Pharmaceutical Inc.; Arcturus Therapeutics Holdings Inc.

Ultragenyx and Arcturus Therapeutics Expand Existing Research Collaboration and License Agreement to Develop Additional Nucleic Acid Therapies for Rare Diseases

Scope of the collaboration expands to include up to 12 rare disease targets and includes Arcturus nucleic acid technologies to enable mRNA, DNA, and siRNA therapeutics$30 million of upfront payments...
June 19, 2019 08:01 ET | Source: Zion Market Research

Global Brain Implants Market Will Reach to USD 831 Million By 2025: Zion Market Research

New York, NY, June 19, 2019 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Brain Implants Market by Product (Deep Brain Stimulator, Spinal Cord Stimulator, and Vagus...
June 19, 2019 08:00 ET | Source: Incysus Therapeutics, Inc.

Incysus Therapeutics Announces Publication of U.S. Patent for Drug Resistant Immunotherapy (DRI) Technology

US Patent and Trademark Office Issues U.S. Patent Covering Drug Resistant Immunotherapy (DRI) TechnologyClaims Provide Initial Protection for Incysus’ Novel DRI PlatformIncysus Controls Exclusive...
June 19, 2019 08:00 ET | Source: biotricity

Biotricity Doubles Sales Force – Expands Device Fleet by 59%

REDWOOD CITY, Calif., June 19, 2019 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it has expanded its...
June 19, 2019 08:00 ET | Source: Intra-Cellular Therapies Inc.

Intra-Cellular Therapies to Present at JMP Securities Life Sciences Conference

NEW YORK, June 19, 2019 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS)...
June 19, 2019 08:00 ET | Source: Acasti Pharma, Inc.

Acasti Pharma Schedules Fourth Quarter and Fiscal 2019 Conference Call

LAVAL, Quebec, June 19, 2019 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and...
June 19, 2019 07:58 ET | Source: InnerScope Hearing Technologies, Inc.

InnerScope Hearing Technologies (OTCQB: INND) Launches Direct-to-Consumer Self-Fitting Hearing Aids with Walmart, Sears, & Kmart

ROSEVILLE, Calif., June 19, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- InnerScope Hearing Technologies Inc. (OTCQB: INND) ("InnerScope"), a manufacturer and Direct-to-Consumer ("DTC")...
June 19, 2019 07:45 ET | Source: Fortune Business Insights

Biliary Tumor Market to Gain Traction in the Coming Years; Advancements in NuCana’s Breakthrough Pipeline Drug Will Boost the Market, says Fortune Business Insights

Pune, June 19, 2019 (GLOBE NEWSWIRE) -- The global Biliary Tumor Market is likely to derive growth from increasing usage approvals in the forthcoming years. According to an upcoming report by...
June 19, 2019 07:39 ET | Source: Akari Therapeutics Plc

Akari Therapeutics’ Nomacopan Demonstrates Positive Early Safety and Efficacy in Phase I/II Clinical Study in Moderate-to-Severe Atopic Keraconjunctivitis (AKC)

Part A of a safety and efficacy study successfully completed with nomacopan eye drops which were well tolerated with no serious adverse events.Improvement in mean composite clinical efficacy score of...
June 19, 2019 07:30 ET | Source: Melinta Therapeutics

Melinta Therapeutics Announces U.S. FDA Acceptance of Supplemental New Drug Application for BAXDELA® (delafloxacin) for the Treatment of Community-Acquired Bacterial Pneumonia

~ Application Seeks to Expand Label to Include an Indication and Phase III Data for the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia (CABP) ~ ~ PDUFA Date Set for October...
June 19, 2019 07:15 ET | Source: Research and Markets

The World Market for Capnography Devices to 2026 - A $1.58 Billion Opportunity with Microstream Capnography Expected to Expand at the Fastest CAGR

Dublin, June 19, 2019 (GLOBE NEWSWIRE) -- The "The World Market for Capnography Devices to 2026" report has been added to ResearchAndMarkets.com's offering. The global capnography...
June 19, 2019 07:05 ET | Source: Myriad Genetics, Inc.

Myriad Genetics社、BRACAnalysis®診断システムで日本における2番目の保険適用を取得

ソルトレークシティ, June 19, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics社（NASDAQ：MYGN）の完全子会社であるMyriad Genetic...
June 19, 2019 07:05 ET | Source: Myriad Genetics, Inc.

Myriad Genetics Receives Second Insurance Reimbursement Decision for its BRACAnalysis® Diagnostic System in Japan

SALT LAKE CITY, June 19, 2019 (GLOBE NEWSWIRE) -- Myriad Genetic Laboratories, Inc., a wholly-owned subsidiary of Myriad Genetics, Inc. (NASDAQ: MYGN), today announced the Japanese Ministry of...